Veterinary Medicines

GALLIMUNE 407 ND+IB+EDS+ART

Authorised
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
Download as PDF

Product identification

Medicine name:
GALLIMUNE 407 ND+IB+EDS+ART
Active substance:
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Ulster 2C, Inactivated
    10.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
    162.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    10.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
    60.00
    interference percentage unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA18
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2016
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 24/01/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 24/01/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 24/01/2023
Download